Skip to main content

Table 1 Genes significantly associated with estrogen receptor (ER)-positive breast cancer that have not been identified in previous TWAS of breast cancer

From: Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status

Loci

Gene Name

Min. 11 Tissue ACAT p-valuea

Min. Breast p-valueb

TWAS-significant Approachesc

Max. PIP (eQTL)d

Max. PIP (sQTL)e

1p34.1-p33

RAD54L

5.24E-07

NA

express

0.56

NA

1p34.1-p33

UQCRH

1.48E-06

9.11E-01

express

0.06

NA

1p34.1-p33

FAAH

7.08E-09

3.39E-07

express|splice

1

0.39

1q21.1, L1

FCGR1CP

5.05E-11

NA

splice

NA

1

1q21.1, L2

ITGA10

1.46E-06

1.91E-06

splice

NA

0.36

1q21.1, L2

HJV

9.75E-07

6.46E-01

splice

NA

0.3

1q22

DPM3

2.51E-06

2.51E-06

splice

NA

0.02

1q22

ARHGEF2

4.02E-07

2.10E-04

express

0.44

NA

3p14.1

THOC7

5.21E-06

5.81E-07

splice

NA

0

3p24.1, L2

TGFBR2

3.47E-09

1.14E-02

express

1

NA

3p26.1

ITPR1

7.41E-11

3.17E-01

splice

NA

1

4q21.23

HELQ

1.16E-06

1.42E-06

splice

NA

0.93

4q34.1

RP13-577H12.2

1.97E-12

NA

splice

NA

1

5q11.1

PARP8

2.96E-06

1.08E-06

express

0

NA

5q14.3

ARRDC3

3.39E-10

9.52E-11

splice

NA

1

5q33.3

EBF1

1.61E-15

NA

splice

NA

1

6p22.1-p21.33

TRIM31

1.43E-06

7.78E-02

express

0.94

NA

6p22.1-p22.2

BTN3A1

1.93E-06

1.24E-06

splice

NA

0.87

6p22.1-p22.2

ABT1

7.41E-07

7.70E-02

splice

NA

0.74

6p22.1-p22.2

ZSCAN9

1.34E-06

9.36E-03

splice

NA

0.12

6p22.1-p22.2

PGBD1

9.86E-07

4.75E-07

splice

NA

0.48

6p22.1-p22.2

ZSCAN23

1.45E-07

8.88E-08

splice

NA

0.55

6p23

SIRT5

5.03E-06

3.31E-06

express

0.76

NA

7q21.2

ANKIB1

6.90E-07

7.75E-07

splice

NA

0.01

10p12.31-p12.2

MLLT10

2.22E-16

1.98E-02

splice

NA

0.5

10p12.31-p12.2

PIP4K2A

4.38E-07

8.95E-07

splice

NA

1

10q21.2-q21.3

EGR2

9.53E-08

9.53E-08

splice

NA

0.98

10q26.13

ENSG00000273767

1.66E-06

NA

splice

NA

0.53

11p15.5, L2

AC051649.12

2.22E-16

NA

splice

NA

0.07

11p15.5, L2

H19

2.96E-09

1.63E-09

splice

NA

0

12q24.21

RP11-116D17.3

1.06E-06

3.14E-01

express

0.95

NA

14q24.1

RAD51B

2.23E-07

8.64E-01

splice

NA

0.99

14q32.11-q32.12

CCDC88C

5.45E-10

8.72E-11

splice

NA

1

14q32.11-q32.12

PPP4R3A

4.79E-07

2.63E-02

splice

NA

0.95

15q22.33

SMAD3

2.31E-06

4.07E-02

splice

NA

0.88

15q24.1

SCAMP2

4.84E-07

3.59E-03

splice

NA

0.93

15q26.1

VPS33B

8.09E-11

6.34E-11

splice

NA

1

16q13

AMFR

2.85E-06

2.85E-06

splice

NA

0.72

17q11.2

ATAD5

5.93E-07

6.22E-01

splice

NA

0.98

18q11.2, L2

CHST9

6.74E-09

NA

splice

NA

1

19p13.13

NACC1

4.72E-07

4.72E-07

splice

NA

0.51

19q13.31

ZNF45

6.32E-12

6.69E-12

splice

NA

1

22q12.1-q12.2

CTA-292E10.6

3.01E-09

8.71E-03

splice

NA

0.9

  1. Abbreviations:
  2. TWAS, transcriptome-wide association study; ER+, estrogen receptor-positive.
  3. a The minimum joint-tissue TWAS p-value between either the expression-based or splicing-based approach.
  4. b The minimum TWAS p-value in breast tissue between either the expression-based approach or splicing-based approach.
  5. c “Express” indicates the listed gene was identified using only the expression-based TWAS approach in either only breast tissue or jointly across all tissues. “splice” indicates the listed gene was identified using only the splicing-based TWAS approach in either only breast tissue or jointly across all tissues. “express|splice” indicates the listed gene was identified in either expression-based or splicing-based approaches in either breast tissue or jointly across all tissues.
  6. d The maximum PIP of an eQTL for a given gene across 11 tissues.
  7. e The maximum PIP of an sQTL for a given gene across 11 tissues.